NeuroRx Announces Completion of Data Analysis in Phase 2b/3 Clinical Trial of ZYESAMI™ for the Treatment of COVID-19 Respiratory Failure ...Middle East

RADNOR, Pa., March 26, 2021 /PRNewswire/ -- NeuroRx, Inc. announces completion of top line data analysis of the 60-day results in its phase 2b/3 clinical trial, conducted under FDA Fast Track Designation, of ZYESAMI™ (aviptadil acetate) for the treatment of critically-ill patients with...

Hence then, the article about neurorx announces completion of data analysis in phase 2b 3 clinical trial of zyesami for the treatment of covid 19 respiratory failure was published today ( Friday 26/03/2021 - 05:00 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( NeuroRx Announces Completion of Data Analysis in Phase 2b/3 Clinical Trial of ZYESAMI™ for the Treatment of COVID-19 Respiratory Failure )

Also on site :

• Armed police close Lewes Road
• Intrigue, Power Plays and Rivalries: Inside the Rise of Mojtaba Khamenei
• Fire erupts at Dubai airport following drone attack